|
|
-
DOYLESTOWN, PA -- (MARKET WIRE)--November 1, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that it has launched the
-
DOYLESTOWN, PA -- (MARKET WIRE)--October 26, 2007 -- QuantRx Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced
-
DOYLESTOWN, PA -- (MARKET WIRE) --October 24, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, announced today that it is scheduled to present
-
DOYLESTOWN, PA -- (MARKET WIRE) -- September 4, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, is pleased to announce it has entered
-
- DOYLESTOWN, PA -- (MARKET WIRE) -- July 31, 2007 -- QuantRx ® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that
-
-
-
-
-
DOYLESTOWN, PA -- (MARKET WIRE) -- June 28, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that FluoroPharma, a QuantRx affiliate, completed 12 healthy
DOYLESTOWN, PA -- (MARKET WIRE) -- May 21, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic
|
| |
|
DOYLESTOWN, PA -- (MARKET WIRE) -- 05/01/2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that Anthony
DOYLESTOWN, PA – April 19, 2007 – QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the development and commercialization of medical diagnostic platforms and products, today announced that it has
DOYLESTOWN, PA -- (MARKET WIRE) -- 03/06/2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced that it
DOYLESTOWN, PA -- (MARKET WIRE) -- January 16, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced
DOYLESTOWN, PA -- (MARKET WIRE) -- January 10, 2007 -- QuantRx® Biomedical Corporation (OTCBB: QTXB), an emerging leader in the research and development of medical diagnostic platforms and products, today announced
|
|
 |
